{
    "organizations": [],
    "uuid": "c8021ffa2a97dd95aa809b989b174ae9e2bdeb70",
    "author": "",
    "url": "https://www.reuters.com/article/brief-fda-approves-toujeo-max-solostar/brief-fda-approves-toujeo-max-solostar-idUSASC09TRY",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Approves Toujeo® Max Solostar®",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 08 PM / Updated 24 minutes ago BRIEF-FDA Approves Toujeo® Max Solostar® Reuters Staff March 27 (Reuters) - Sanofi Sa: * FDA APPROVES TOUJEO® MAX SOLOSTAR® * SANOFI - FDA APPROVED SANOFI’S TOUJEO (INSULIN GLARGINE 300 UNITS/ML) MAX SOLOSTAR Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)",
    "published": "2018-03-27T15:05:00.000+03:00",
    "crawled": "2018-03-27T15:36:20.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "approves",
        "max",
        "reuters",
        "staff",
        "march",
        "reuters",
        "sanofi",
        "sa",
        "fda",
        "approves",
        "max",
        "sanofi",
        "fda",
        "approved",
        "sanofi",
        "toujeo",
        "insulin",
        "glargine",
        "max",
        "solostar",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}